Search clinical trials for: Trastuzumab (Herceptin®)
Total 14959 results
-
Daiichi Sankyo Co., Ltd.AstraZeneca; Daiichi Sankyo, Inc.CompletedColorectal NeoplasmUnited States, Spain, Japan, Italy, United Kingdom
-
Second Affiliated Hospital, School of Medicine,...Zhejiang Cancer Hospital; First Affiliated Hospital of Zhejiang University; Sir... and other collaboratorsUnknownColorectal CancerChina
-
European Organisation for Research and Treatment...Hoffmann-La Roche; UNICANCER; Janssen Diagnostics, LLC; SUCCESSCompletedBreast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Circulating Tumor CellsFrance, Germany, Belgium, United Kingdom
-
Centre Antoine LacassagneCompleted
-
MedSIRDaiichi SankyoNot yet recruitingBreast Cancer | Metastatic Breast Cancer
-
Memorial Sloan Kettering Cancer CenterCompletedBreast CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingMetastatic Breast CancerChina
-
Seoul National University Bundang HospitalRoche Pharma AG; Korean Cancer Study GroupRecruitingSolid Tumor | Metastatic Cancer | Advanced Solid TumorKorea, Republic of
-
Celularity IncorporatedActive, not recruitingMetastatic HER2 Positive Gastroesophageal Junction CancerUnited States
-
West China HospitalJiangsu HengRui Medicine Co., Ltd.UnknownBreast Cancer | HER2 Positive | Combination ChemotherapyChina
-
Austrian Breast & Colorectal Cancer Study GroupSanofi; Hoffmann-La Roche; Amgen; Ebewe Pharma GmbHCompleted
-
University of NebraskaNational Cancer Institute (NCI)CompletedStage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast CancerUnited States
-
NSABP Foundation IncNational Cancer Institute (NCI)Completed
-
University of FloridaCompleted
-
Shengjing HospitalNot yet recruiting
-
Baylor Breast Care CenterGlaxoSmithKline; Translational Breast Cancer Research ConsortiumActive, not recruitingBreast CancerUnited States
-
Alliance Foundation Trials, LLC.Pfizer; Syneos Health; UNICANCER; German Breast Group; SOLTI Breast Cancer Research... and other collaboratorsActive, not recruitingHER-2 Positive Breast Cancer | Estrogen Receptor Positive Breast CancerUnited States, Spain, France, Italy, Germany, Australia, Portugal, New Zealand
-
Fudan UniversityRecruiting
-
Susanne CrocamoCompletedNeoplasms | Neoplasms by Site | Breast Cancer | Breast DiseaseBrazil
-
Peking UniversityRecruitingHER2-positive Breast CancerChina
-
Hoffmann-La RocheGenentech, Inc.; Breast International GroupActive, not recruitingBreast CancerUnited States, Belgium, Canada, Australia, Austria, Bulgaria, China, Croatia, Denmark, France, Germany, Guatemala, Hungary, Ireland, Italy, Korea, Republic of, Panama, Slovenia, Spain, Taiwan, United Kingdom, Colombia, Czechia, El Salvador and more
-
Washington University School of MedicinePfizer; Rising Tide FoundationTerminatedBreast Cancer | Breast Carcinoma | Cancer of BreastUnited States
-
iOMEDICO AGAmgen; Arbeitsgemeinschaft fur Internistische OnkologieWithdrawnAdvanced Breast Cancer | HER2-positive Breast CancerGermany
-
Hoffmann-La RocheChugai PharmaceuticalCompletedBreast CancerKorea, Republic of, Canada, Brazil, Germany, Italy, Spain, Japan, Czechia, Poland, United States, Russian Federation, Taiwan
-
Renske AltenaTerminatedHER2-positive Breast Cancer | Early-stage Breast CancerSweden
-
Hoffmann-La RocheCompletedBreast CancerUnited States, France, Czechia, Italy, Korea, Republic of, Australia, Belgium, Brazil, Canada, Germany, Guatemala, Hong Kong, Hungary, Panama, Peru, Poland, Spain, Taiwan, United Kingdom, Colombia, Bosnia and Herzegovina, Chile, El... and more
-
Genentech, Inc.Completed
-
Jenny C. Chang, MDGenentech, Inc.; The Methodist Hospital Research InstituteWithdrawnBreast CancerUnited States
-
National Cancer Institute (NCI)CompletedCombination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast CancerStage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Genentech, Inc.CompletedNeoplasms | Bladder Cancer | Solid Tumors | Biliary Cancer | Salivary CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompleted
-
University of Colorado, DenverChildren's Hospital ColoradoRecruitingPosterior Fossa Ependymoma (PFEPN)United States
-
National University Hospital, SingaporeNational Cancer Centre, SingaporeUnknown
-
Guangdong Provincial People's HospitalRecruitingNeoadjuvant Therapies for HER2+ Breast CancerChina
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdUnknown
-
Institut Paoli-CalmettesInnate PharmaRecruitingMetastatic Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Endometrial Cancer | Metastatic Gastric Cancer | Metastatic Pancreatic Cancer | Oesophageal Cancer | Metastatic Ovary CancerFrance
-
Hospices Civils de LyonNot yet recruiting
-
Institut du Cancer de Montpellier - Val d'AurelleCompleted
-
Hebei Medical University Fourth HospitalOrigiMedRecruitingProspective | ObservationalChina
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingHER2-positive Breast CancerChina
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La Roche; CephalonCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
Assistance Publique - Hôpitaux de ParisRecruitingAlzheimer Disease | Huntington DiseaseFrance
-
Istituto per la Ricerca e l'Innovazione BiomedicaRecruiting
-
The Netherlands Cancer InstituteAstraZeneca; Daiichi SankyoRecruiting
-
Fudan UniversityRecruitingEffect of Drug | Gastrointestinal TumorChina